New England Biolabs launches primer tool for SARS-CoV-2 variant tracking

By The Science Advisory Board staff writers

June 11, 2021 -- New England Biolabs has launched an open access, web-based tool for monitoring the emergence of SARS-CoV-2 variants and their potential effect on COVID-19 diagnostic tests.

The Primer Monitor Tool is updated regularly and provides visualization of known variants identified in the SARS-CoV-2 genome. It also offers insight into where commonly used or user-defined primer set assessment may be worthwhile.

The tool is powered by data from the Global Initiative on Sharing All Influenza Data (GISAID), an international science initiative and primary source that provides open access to genomic data of influenza viruses and SARS-CoV-2.

New England Biolabs supports SARS-CoV-2 monitoring with NGS kits
New England Biolabs has launched three next-generation sequencing (NGS) kits based on Artic Network protocols for multiplexed amplicon-based sequencing...

Copyright © 2021

Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter